Drug Approval Package: BENDAMUSTINE HYDROCHLORIDE

Company: Baxter Healthcare Corporation
Application Number: 216078
Approval Date: 12/22/2022

Drugs@FDA information available about BENDAMUSTINE HYDROCHLORIDE

Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance.

FDA Approval Letter and Labeling

• Approval Letter(s) (PDF)
• Printed Labeling (PDF)

FDA Application Review Files

• Product Quality Review(s) (PDF)
• Clinical Review(s) (PDF)
• Other Action Letters (PDF)
• Non-Clinical Review(s) (PDF)
• Officer/Employee List (PDF)
• Other Review(s) (PDF)
• Summary Review (PDF)

Date created: December 15, 2023

Vision impaired people having problems accessing certain pages of a PDF file may call (301) 796-3634 for assistance.

Note: Documents in PDF format require the Adobe Acrobat Reader®.